O	O	0	10	Activation	Activation	B-NP	NN	O	0	ROOT	O
O	O	11	13	of	of	B-PP	IN	O	1	NMOD	O
T11	B-Entity	14	21	nuclear	nuclear	B-NP	JJ	B-protein	7	NMOD	B-protein
T11	I-Entity	22	28	factor	factor	I-NP	NN	I-protein	7	NMOD	I-protein
T11	I-Entity	28	29	-	-	B-NP	HYPH	I-protein	7	NMOD	I-protein
T11	I-Entity	29	34	kappa	kappa	I-NP	NN	I-protein	7	NMOD	I-protein
T11	I-Entity	35	36	B	B	I-NP	NN	I-protein	2	PMOD	I-protein
O	O	37	39	by	by	B-PP	IN	O	1	NMOD	O
T12	B-Entity	40	44	beta	beta	B-NP	SYM	O	12	NMOD	O
T12	I-Entity	44	45	-	-	B-NP	HYPH	O	12	NMOD	O
T12	I-Entity	45	52	amyloid	amyloid	I-NP	JJ	O	12	NMOD	O
T12	I-Entity	53	61	peptides	peptide	I-NP	NNS	O	16	NMOD	O
O	O	62	65	and	and	I-NP	CC	O	16	NMOD	O
T1	B-Protein	66	76	interferon	interferon	I-NP	NN	B-protein	16	NMOD	B-protein
T1	I-Protein	76	77	-	-	O	HYPH	I-protein	16	NMOD	I-protein
T1	I-Protein	77	82	gamma	gamma	B-NP	NN	I-protein	8	PMOD	I-protein
O	O	83	85	in	in	B-PP	IN	O	16	NMOD	O
O	O	86	92	murine	murine	B-NP	JJ	B-cell_type	19	NMOD	B-cell_type
O	O	93	102	microglia	microglia	I-NP	NNS	I-cell_type	17	PMOD	I-cell_type
O	O	102	103	.	.	O	.	O	1	P	O

O	O	105	107	An	An	B-NP	DT	O	3	NMOD	O
O	O	108	118	increasing	increase	I-NP	VBG	O	3	NMOD	O
O	O	119	123	body	body	I-NP	NN	O	6	SUB	O
O	O	124	126	of	of	B-PP	IN	O	3	NMOD	O
O	O	127	135	evidence	evidence	B-NP	NN	O	4	PMOD	O
O	O	136	144	suggests	suggest	B-VP	VBZ	O	0	ROOT	O
O	O	145	149	that	that	B-SBAR	IN	O	6	VMOD	O
T13	B-Entity	150	157	amyloid	amyloid	B-NP	NN	O	10	NMOD	O
T13	I-Entity	157	158	-	-	O	HYPH	O	10	P	O
T13	I-Entity	158	162	beta	beta	B-NP	SYM	O	17	NMOD	O
T13	I-Entity	163	164	(	(	O	(	O	14	DEP	O
T13	I-Entity	164	165	A	A	O	NN	O	13	NMOD	O
T13	I-Entity	166	170	beta	beta	O	SYM	O	14	DEP	O
T13	I-Entity	170	171	)	)	O	)	O	10	NMOD	O
T13	I-Entity	172	180	peptides	peptide	B-NP	NNS	O	17	NMOD	O
O	O	181	184	and	and	I-NP	CC	O	17	NMOD	O
O	O	185	194	microglia	microglia	I-NP	NNS	B-cell_type	18	SUB	B-cell_type
O	O	195	198	are	be	B-VP	VBP	O	7	SBAR	O
O	O	199	208	crucially	crucially	I-VP	RB	O	18	VMOD	O
O	O	209	217	involved	involve	I-VP	VBN	O	18	VC	O
O	O	218	220	in	in	B-PP	IN	O	20	VMOD	O
O	O	221	224	the	the	B-NP	DT	O	23	NMOD	O
O	O	225	237	pathogenesis	pathogenesis	I-NP	NN	O	21	PMOD	O
O	O	238	240	of	of	B-PP	IN	O	23	NMOD	O
O	O	241	250	Alzheimer	Alzheimer	B-NP	NNP	O	28	NMOD	O
O	O	250	251	'	'	B-NP	POS	O	28	NMOD	O
O	O	251	252	s	s	I-NP	JJ	O	28	NMOD	O
O	O	253	260	disease	disease	I-NP	NN	O	24	PMOD	O
O	O	260	261	.	.	O	.	O	6	P	O

O	O	262	264	In	In	B-PP	IN	O	17	VMOD	O
O	O	265	267	an	an	B-NP	DT	O	3	NMOD	O
O	O	268	274	effort	effort	I-NP	NN	O	1	PMOD	O
O	O	275	277	to	to	B-VP	TO	O	6	VMOD	O
O	O	278	285	further	further	I-VP	RB	O	6	VMOD	O
O	O	286	295	elucidate	elucidate	I-VP	VB	O	3	NMOD	O
O	O	296	299	the	the	B-NP	DT	O	9	NMOD	O
O	O	300	310	biological	biological	I-NP	JJ	O	9	NMOD	O
O	O	311	318	effects	effect	I-NP	NNS	O	6	OBJ	O
O	O	319	321	of	of	B-PP	IN	O	9	NMOD	O
T14	B-Entity	322	323	A	A	B-NP	NN	O	12	NMOD	O
T14	I-Entity	324	328	beta	beta	B-NP	SYM	O	10	PMOD	O
O	O	329	336	towards	towards	B-PP	IN	O	9	NMOD	O
O	O	337	346	microglia	microglia	B-NP	NNS	B-cell_type	13	PMOD	B-cell_type
O	O	346	347	,	,	O	,	O	17	P	O
O	O	348	350	we	we	B-NP	PRP	O	17	SUB	O
O	O	351	363	investigated	investigate	B-VP	VBD	O	0	ROOT	O
O	O	364	367	the	the	B-NP	DT	O	19	NMOD	O
O	O	368	375	ability	ability	I-NP	NN	O	17	OBJ	O
O	O	376	378	of	of	B-PP	IN	O	19	NMOD	O
T15	B-Entity	379	380	A	A	B-NP	NN	O	23	NMOD	O
T15	I-Entity	381	385	beta	beta	I-NP	NN	O	23	NMOD	O
T15	I-Entity	386	394	peptides	peptide	I-NP	NNS	O	20	PMOD	O
O	O	395	397	to	to	B-VP	TO	O	25	VMOD	O
O	O	398	406	activate	activate	I-VP	VB	O	19	NMOD	O
T16	B-Entity	407	414	nuclear	nuclear	B-NP	JJ	B-protein	33	NMOD	B-protein
T16	I-Entity	415	421	factor	factor	I-NP	NN	I-protein	33	NMOD	I-protein
T16	I-Entity	422	423	(	(	O	(	I-protein	33	NMOD	I-protein
T16	I-Entity	423	425	NF	NF	B-NP	NN	I-protein	33	NMOD	I-protein
T16	I-Entity	425	426	)	)	O	)	I-protein	33	NMOD	I-protein
T16	I-Entity	426	427	-	-	B-NP	HYPH	I-protein	33	NMOD	I-protein
T16	I-Entity	427	432	kappa	kappa	I-NP	NN	I-protein	33	NMOD	I-protein
T16	I-Entity	433	434	B	B	I-NP	NN	I-protein	25	OBJ	I-protein
O	O	435	437	in	in	B-PP	IN	O	25	VMOD	O
O	O	438	441	the	the	B-NP	DT	O	40	NMOD	O
O	O	442	444	N9	N9	I-NP	NN	B-cell_line	40	NMOD	B-cell_line
O	O	445	451	murine	murine	I-NP	JJ	I-cell_line	40	NMOD	I-cell_line
O	O	452	462	microglial	microglial	I-NP	JJ	I-cell_line	40	NMOD	I-cell_line
O	O	463	467	cell	cell	I-NP	NN	I-cell_line	40	NMOD	I-cell_line
O	O	468	472	line	line	I-NP	NN	I-cell_line	34	PMOD	I-cell_line
O	O	472	473	.	.	O	.	O	17	P	O

O	O	474	476	Co	Co	B-NP	AFX	B-DNA	3	NMOD	B-DNA
O	O	476	477	-	-	I-NP	HYPH	O	3	NMOD	O
O	O	477	488	stimulation	stimulation	B-NP	NN	O	24	SUB	O
O	O	489	491	of	of	B-PP	IN	O	3	NMOD	O
O	O	492	501	microglia	microglia	B-NP	NNS	B-cell_type	4	PMOD	B-cell_type
O	O	502	506	with	with	B-PP	IN	O	3	NMOD	O
O	O	507	517	suboptimal	suboptimal	B-NP	JJ	O	8	NMOD	O
O	O	518	532	concentrations	concentration	I-NP	NNS	O	6	PMOD	O
O	O	533	535	of	of	B-PP	IN	O	8	NMOD	O
T17	B-Entity	536	537	A	A	B-NP	NN	O	11	NMOD	O
T17	I-Entity	538	542	beta	beta	I-NP	NN	O	23	NMOD	O
O	O	542	543	(	(	O	(	O	16	DEP	O
O	O	543	545	25	25	B-NP	CD	O	15	NMOD	O
O	O	545	546	-	-	I-NP	HYPH	O	15	P	O
O	O	546	548	35	35	I-NP	CD	O	16	DEP	O
O	O	548	549	)	)	O	)	O	11	NMOD	O
O	O	550	553	and	and	O	CC	O	23	NMOD	O
O	O	554	557	100	100	B-NP	CD	O	23	NMOD	O
O	O	558	559	U	U	I-NP	NN	O	23	NMOD	O
O	O	559	560	/	/	B-NP	SYM	O	23	NMOD	O
O	O	560	562	ml	ml	I-NP	NN	O	23	NMOD	O
T2	B-Protein	563	566	IFN	IFN	I-NP	NN	B-protein	23	NMOD	B-protein
T2	I-Protein	567	572	gamma	gamma	I-NP	NN	I-protein	9	PMOD	I-protein
O	O	573	581	resulted	result	B-VP	VBD	O	0	ROOT	O
O	O	582	584	in	in	B-PP	IN	O	24	VMOD	O
O	O	585	588	the	the	B-NP	DT	O	27	NMOD	O
O	O	589	598	detection	detection	I-NP	NN	O	25	PMOD	O
O	O	599	601	of	of	B-PP	IN	O	27	NMOD	O
O	O	602	603	a	a	B-NP	DT	O	35	NMOD	O
O	O	604	612	specific	specific	I-NP	JJ	O	35	NMOD	O
T18	B-Entity	613	615	NF	NF	I-NP	NN	O	35	NMOD	O
T18	I-Entity	615	616	-	-	I-NP	HYPH	O	35	P	O
T18	I-Entity	616	621	kappa	kappa	I-NP	NN	B-DNA	35	NMOD	B-DNA
T18	I-Entity	622	623	B	B	I-NP	NN	I-DNA	35	NMOD	I-DNA
T19	I-Entity	624	627	DNA	DNA	I-NP	NN	I-DNA	38	NMOD	I-DNA
O	O	627	628	-	-	B-NP	HYPH	O	38	NMOD	O
O	O	628	635	binding	binding	I-NP	NN	O	38	NMOD	O
O	O	636	644	activity	activity	I-NP	NN	O	28	PMOD	O
O	O	645	647	in	in	B-PP	IN	O	38	NMOD	O
O	O	648	655	nuclear	nuclear	B-NP	JJ	O	41	NMOD	O
O	O	656	664	extracts	extract	I-NP	NNS	O	39	PMOD	O
O	O	664	665	,	,	O	,	O	24	P	O
O	O	666	668	as	as	B-SBAR	IN	O	24	VMOD	O
O	O	669	679	determined	determine	B-VP	VBN	O	43	SBAR	O
O	O	680	682	in	in	B-PP	IN	O	44	VMOD	O
O	O	683	686	gel	gel	B-NP	NN	O	49	NMOD	O
O	O	687	695	mobility	mobility	I-NP	NN	O	49	NMOD	O
O	O	696	701	shift	shift	I-NP	NN	O	49	NMOD	O
O	O	702	708	assays	assay	I-NP	NNS	O	45	PMOD	O
O	O	708	709	.	.	O	.	O	24	P	O

O	O	710	714	This	This	B-NP	DT	O	2	NMOD	O
O	O	715	723	response	response	I-NP	NN	O	3	SUB	O
O	O	724	732	required	require	B-VP	VBD	O	14	VMOD	O
O	O	733	735	at	at	B-NP	IN	O	7	NMOD	O
O	O	736	741	least	least	I-NP	JJS	O	4	AMOD	O
O	O	742	745	120	120	I-NP	CD	O	4	AMOD	O
O	O	746	749	min	min	I-NP	NN	O	3	OBJ	O
O	O	750	752	to	to	B-VP	TO	O	9	VMOD	O
O	O	753	755	be	be	I-VP	VB	O	3	VMOD	O
O	O	756	763	evident	evident	B-NP	JJ	O	9	PRD	O
O	O	764	767	and	and	I-NP	CC	O	14	VMOD	O
O	O	768	778	supershift	supershift	I-NP	NN	O	13	NMOD	O
O	O	779	790	experiments	experiment	I-NP	NNS	O	14	SUB	O
O	O	791	799	revealed	reveal	B-VP	VBD	O	0	ROOT	O
O	O	800	804	that	that	B-SBAR	IN	O	14	VMOD	O
O	O	805	808	the	the	B-NP	DT	O	21	NMOD	O
T20	B-Entity	809	811	NF	NF	I-NP	NN	B-protein	21	NMOD	B-protein
T20	I-Entity	811	812	-	-	B-NP	HYPH	I-protein	21	NMOD	I-protein
T20	I-Entity	812	817	kappa	kappa	I-NP	NN	I-protein	21	NMOD	I-protein
T20	I-Entity	818	819	B	B	I-NP	NN	I-protein	21	NMOD	I-protein
T20	I-Entity	820	827	complex	complex	I-NP	NN	I-protein	22	SUB	I-protein
O	O	828	836	contains	contain	B-VP	VBZ	O	15	SBAR	O
O	O	837	841	both	both	O	CC	O	26	NMOD	O
T3	B-Protein	842	846	RelA	RelA	B-NP	NN	B-protein	26	NMOD	B-protein
O	O	847	850	and	and	I-NP	CC	O	26	NMOD	O
T4	B-Protein	851	854	p50	p50	I-NP	NN	B-protein	22	OBJ	B-protein
O	O	854	855	.	.	O	.	O	14	P	O

O	O	856	867	Accordingly	Accordingly	B-ADVP	RB	O	5	VMOD	O
O	O	867	868	,	,	O	,	O	5	P	O
O	O	869	879	immunoblot	immunoblot	B-NP	NN	O	4	NMOD	O
O	O	880	891	experiments	experiment	I-NP	NNS	O	5	SUB	O
O	O	892	898	showed	show	B-VP	VBD	O	0	ROOT	O
O	O	899	903	that	that	B-SBAR	IN	O	5	VMOD	O
O	O	904	911	amongst	amongst	B-PP	IN	O	19	VMOD	O
T21	B-Entity	912	914	NF	NF	B-NP	NN	B-protein	11	NMOD	B-protein
T21	I-Entity	914	915	-	-	O	HYPH	I-protein	11	NMOD	I-protein
T21	I-Entity	915	920	kappa	kappa	B-NP	NN	I-protein	11	NMOD	I-protein
T21	I-Entity	921	922	B	B	I-NP	NN	I-protein	14	NMOD	I-protein
O	O	922	923	/	/	B-NP	SYM	O	14	NMOD	O
O	O	923	926	Rel	Rel	I-NP	NN	B-protein	14	NMOD	B-protein
O	O	927	935	proteins	protein	I-NP	NNS	I-protein	7	PMOD	I-protein
O	O	935	936	,	,	O	,	O	19	P	O
T5	B-Protein	937	941	RelA	RelA	B-NP	NN	B-protein	18	NMOD	B-protein
O	O	942	945	and	and	I-NP	CC	O	18	NMOD	O
T6	B-Protein	946	949	p50	p50	I-NP	NN	B-protein	19	SUB	B-protein
O	O	950	953	are	be	B-VP	VBP	O	6	SBAR	O
O	O	954	963	mobilized	mobilize	I-VP	VBN	O	19	VC	O
O	O	964	966	to	to	B-PP	TO	O	20	VMOD	O
O	O	967	970	the	the	B-NP	DT	O	23	NMOD	O
O	O	971	978	nucleus	nucleus	I-NP	NN	O	21	PMOD	O
O	O	979	988	following	follow	B-PP	VBG	O	20	VMOD	O
O	O	989	999	microglial	microglial	B-NP	JJ	O	27	NMOD	O
O	O	1000	1004	cell	cell	I-NP	NN	O	27	NMOD	O
O	O	1005	1016	stimulation	stimulation	I-NP	NN	O	24	PMOD	O
O	O	1017	1021	with	with	B-PP	IN	O	27	NMOD	O
T22	B-Entity	1022	1023	A	A	B-NP	NN	O	30	NMOD	O
T22	I-Entity	1024	1028	beta	beta	I-NP	NN	O	38	NMOD	O
O	O	1028	1029	(	(	O	(	O	35	DEP	O
O	O	1029	1031	25	25	B-NP	CD	O	34	NMOD	O
O	O	1031	1032	-	-	I-NP	HYPH	O	34	P	O
O	O	1032	1034	35	35	I-NP	CD	O	35	DEP	O
O	O	1034	1035	)	)	O	)	O	30	NMOD	O
O	O	1036	1040	plus	plus	O	CC	O	38	NMOD	O
T7	B-Protein	1041	1044	IFN	IFN	B-NP	NN	B-protein	38	NMOD	B-protein
T7	I-Protein	1045	1050	gamma	gamma	I-NP	NN	I-protein	28	PMOD	I-protein
O	O	1050	1051	.	.	O	.	O	5	P	O

O	O	1052	1058	Higher	High	B-NP	JJR	O	2	NMOD	O
O	O	1059	1073	concentrations	concentration	I-NP	NNS	O	11	SUB	O
O	O	1074	1076	of	of	B-PP	IN	O	2	NMOD	O
T23	B-Entity	1077	1078	A	A	B-NP	NN	O	5	NMOD	O
T23	I-Entity	1079	1083	beta	beta	I-NP	NN	O	3	PMOD	O
O	O	1083	1084	(	(	O	(	O	10	DEP	O
O	O	1084	1086	25	25	B-NP	CD	O	9	NMOD	O
O	O	1086	1087	-	-	I-NP	HYPH	O	9	P	O
O	O	1087	1089	35	35	I-NP	CD	O	10	DEP	O
O	O	1089	1090	)	)	O	)	O	5	NMOD	O
O	O	1091	1095	were	be	B-VP	VBD	O	0	ROOT	O
O	O	1096	1105	effective	effective	B-ADJP	JJ	O	11	PRD	O
O	O	1106	1108	by	by	B-PP	IN	O	12	AMOD	O
O	O	1109	1119	themselves	themselves	B-NP	PRP	O	13	PMOD	O
O	O	1120	1122	in	in	B-PP	IN	O	12	AMOD	O
O	O	1123	1131	inducing	induce	B-VP	VBG	O	15	PMOD	O
T24	B-Entity	1132	1134	NF	NF	B-NP	NN	B-protein	21	NMOD	B-protein
T24	I-Entity	1134	1135	-	-	B-NP	HYPH	I-protein	21	NMOD	I-protein
T24	I-Entity	1135	1140	kappa	kappa	I-NP	NN	I-protein	21	NMOD	I-protein
T24	I-Entity	1141	1142	B	B	I-NP	NN	I-protein	21	NMOD	I-protein
O	O	1143	1153	activation	activation	I-NP	NN	O	16	OBJ	O
O	O	1153	1154	,	,	O	,	O	11	P	O
O	O	1155	1159	both	both	O	CC	O	22	AMOD	O
O	O	1160	1162	in	in	B-PP	IN	O	23	PMOD	O
O	O	1163	1166	the	the	B-NP	DT	O	29	NMOD	O
O	O	1167	1169	N9	N9	I-NP	NN	B-cell_line	29	NMOD	B-cell_line
O	O	1170	1180	microglial	microglial	I-NP	JJ	I-cell_line	29	NMOD	I-cell_line
O	O	1181	1185	cell	cell	I-NP	NN	I-cell_line	29	NMOD	I-cell_line
O	O	1186	1190	line	line	I-NP	NN	I-cell_line	24	PMOD	I-cell_line
O	O	1191	1194	and	and	B-PP	CC	O	23	PMOD	O
O	O	1195	1197	in	in	B-PP	IN	O	23	PMOD	O
O	O	1198	1201	rat	rat	B-NP	NN	B-cell_line	34	NMOD	B-cell_line
O	O	1202	1209	primary	primary	I-NP	JJ	I-cell_line	34	NMOD	I-cell_line
O	O	1210	1219	microglia	microglia	I-NP	NNS	I-cell_line	31	PMOD	I-cell_line
O	O	1219	1220	,	,	O	,	O	23	P	O
O	O	1221	1223	as	as	B-CONJP	RB	O	35	ROOT	O
O	O	1224	1228	well	well	I-CONJP	RB	O	36	DEP	O
O	O	1229	1231	as	as	I-CONJP	IN	O	36	DEP	O
O	O	1232	1234	in	in	B-PP	IN	O	36	DEP	O
O	O	1235	1240	human	human	B-NP	JJ	B-cell_type	41	NMOD	B-cell_type
O	O	1241	1250	monocytes	monocyte	I-NP	NNS	I-cell_type	39	PMOD	I-cell_type
O	O	1250	1251	.	.	O	.	O	36	P	O

O	O	1252	1255	For	For	B-PP	IN	O	7	VMOD	O
O	O	1256	1264	purposes	purpose	B-NP	NNS	O	1	PMOD	O
O	O	1265	1267	of	of	B-PP	IN	O	2	NMOD	O
O	O	1268	1278	comparison	comparison	B-NP	NN	O	3	PMOD	O
O	O	1278	1279	,	,	O	,	O	7	P	O
O	O	1280	1289	microglia	microglia	B-NP	NNS	B-cell_type	7	SUB	B-cell_type
O	O	1290	1294	were	be	B-VP	VBD	O	0	ROOT	O
O	O	1295	1299	also	also	I-VP	RB	O	7	VMOD	O
O	O	1300	1310	stimulated	stimulate	I-VP	VBN	O	7	VC	O
O	O	1311	1315	with	with	B-PP	IN	O	9	VMOD	O
O	O	1316	1325	bacterial	bacterial	B-NP	JJ	O	12	NMOD	O
O	O	1326	1329	LPS	LPS	I-NP	NN	O	10	PMOD	O
O	O	1329	1330	,	,	O	,	O	9	P	O
O	O	1331	1332	a	a	B-NP	DT	O	20	NMOD	O
O	O	1333	1338	known	know	I-NP	VBN	O	20	NMOD	O
T25	B-Entity	1339	1341	NF	NF	I-NP	NN	B-protein	20	NMOD	B-protein
T25	I-Entity	1341	1342	-	-	I-NP	HYPH	I-protein	20	NMOD	I-protein
T25	I-Entity	1342	1347	kappa	kappa	I-NP	NN	I-protein	20	NMOD	I-protein
T25	I-Entity	1348	1349	B	B	I-NP	NN	I-protein	20	NMOD	I-protein
O	O	1350	1357	inducer	inducer	I-NP	NN	O	9	VMOD	O
O	O	1357	1358	.	.	O	.	O	7	P	O

O	O	1359	1361	As	As	B-SBAR	IN	O	6	VMOD	O
O	O	1362	1370	expected	expect	B-VP	VBN	O	1	SBAR	O
O	O	1370	1371	,	,	O	,	O	6	P	O
O	O	1372	1375	LPS	LPS	B-NP	NN	O	6	SUB	O
O	O	1376	1384	strongly	strongly	B-ADVP	RB	O	6	VMOD	O
O	O	1385	1392	induced	induce	B-VP	VBD	O	0	ROOT	O
O	O	1393	1396	the	the	B-NP	DT	O	8	NMOD	O
O	O	1397	1406	formation	formation	I-NP	NN	O	6	OBJ	O
O	O	1407	1409	of	of	B-PP	IN	O	8	NMOD	O
O	O	1410	1413	two	two	B-NP	CD	O	18	NMOD	O
T26	B-Entity	1414	1416	NF	NF	I-NP	NN	O	15	NMOD	O
T26	I-Entity	1416	1417	-	-	B-NP	HYPH	O	15	P	O
T26	I-Entity	1417	1422	kappa	kappa	I-NP	NN	B-DNA	15	NMOD	B-DNA
T26	I-Entity	1423	1424	B	B	I-NP	NN	I-DNA	15	NMOD	I-DNA
T27	I-Entity	1425	1428	DNA	DNA	I-NP	NN	I-DNA	18	NMOD	I-DNA
O	O	1428	1429	-	-	B-VP	HYPH	O	18	NMOD	O
O	O	1429	1436	binding	bind	B-NP	VBG	O	18	NMOD	O
O	O	1437	1447	activities	activity	I-NP	NNS	O	9	PMOD	O
O	O	1447	1448	,	,	O	,	O	18	P	O
O	O	1449	1452	one	one	B-NP	CD	O	21	NMOD	O
O	O	1453	1455	of	of	B-PP	IN	O	18	NMOD	O
O	O	1456	1461	which	which	B-NP	WDT	O	21	PMOD	O
O	O	1462	1465	was	be	B-VP	VBD	O	21	SBAR	O
O	O	1466	1476	identified	identify	I-VP	VBN	O	23	VC	O
O	O	1477	1479	as	as	B-PP	IN	O	24	VMOD	O
T8,T28	B-Protein,B-Entity	1480	1484	RelA	RelA	B-NP	NN	B-protein	28	NMOD	B-protein
T28	I-Entity	1484	1485	/	/	B-NP	SYM	O	28	NMOD	O
T9,T28	B-Protein,I-Entity	1485	1488	p50	p50	I-NP	NN	B-protein	25	PMOD	B-protein
O	O	1488	1489	.	.	O	.	O	6	P	O

O	O	1490	1493	The	The	B-NP	DT	O	3	NMOD	O
O	O	1494	1497	LPS	LPS	I-NP	NN	O	3	NMOD	O
O	O	1498	1506	response	response	I-NP	NN	O	4	SUB	O
O	O	1507	1510	was	be	B-VP	VBD	O	0	ROOT	O
O	O	1511	1515	also	also	B-ADVP	RB	O	4	VMOD	O
O	O	1516	1520	more	more	B-ADJP	RBR	O	7	AMOD	O
O	O	1521	1526	rapid	rapid	I-ADJP	JJ	O	4	PRD	O
O	O	1526	1527	,	,	O	,	O	4	P	O
O	O	1528	1530	as	as	B-SBAR	IN	O	4	VMOD	O
O	O	1531	1533	it	it	B-NP	PRP	O	11	SUB	O
O	O	1534	1537	was	be	B-VP	VBD	O	9	SBAR	O
O	O	1538	1545	already	already	B-ADVP	RB	O	11	VMOD	O
O	O	1546	1553	evident	evident	B-ADJP	JJ	O	11	PRD	O
O	O	1554	1556	by	by	B-PP	IN	O	13	AMOD	O
O	O	1557	1559	40	40	B-NP	CD	O	16	NMOD	O
O	O	1560	1563	min	min	I-NP	NN	O	14	PMOD	O
O	O	1564	1567	and	and	O	CC	O	11	VMOD	O
O	O	1568	1576	remained	remain	B-VP	VBD	O	11	VMOD	O
O	O	1577	1586	sustained	sustained	B-ADJP	JJ	O	18	PRD	O
O	O	1587	1590	for	for	B-PP	IN	O	19	AMOD	O
O	O	1591	1593	up	up	B-NP	IN	O	24	NMOD	O
O	O	1594	1596	to	to	I-NP	TO	O	21	AMOD	O
O	O	1597	1598	3	3	I-NP	CD	O	21	AMOD	O
O	O	1599	1600	h	h	I-NP	NN	O	20	PMOD	O
O	O	1600	1601	.	.	O	.	O	4	P	O

O	O	1602	1614	Collectively	Collectively	B-ADVP	RB	O	5	VMOD	O
O	O	1614	1615	,	,	O	,	O	5	P	O
O	O	1616	1621	these	these	B-NP	DT	O	4	NMOD	O
O	O	1622	1630	findings	finding	I-NP	NNS	O	5	SUB	O
O	O	1631	1639	indicate	indicate	B-VP	VBP	O	0	ROOT	O
O	O	1640	1644	that	that	B-SBAR	IN	O	5	VMOD	O
T29	B-Entity	1645	1647	NF	NF	B-NP	NN	B-protein	10	NMOD	B-protein
T29	I-Entity	1647	1648	-	-	B-NP	HYPH	I-protein	10	NMOD	I-protein
T29	I-Entity	1648	1653	kappa	kappa	I-NP	NN	I-protein	10	NMOD	I-protein
T29	I-Entity	1654	1655	B	B	I-NP	NN	I-protein	11	NMOD	I-protein
O	O	1656	1666	activation	activation	I-NP	NN	O	12	SUB	O
O	O	1667	1672	might	might	B-VP	MD	O	6	SBAR	O
O	O	1673	1683	constitute	constitute	I-VP	VB	O	12	VC	O
O	O	1684	1687	one	one	B-NP	CD	O	13	OBJ	O
O	O	1688	1690	of	of	B-PP	IN	O	14	NMOD	O
O	O	1691	1694	the	the	B-NP	DT	O	17	NMOD	O
O	O	1695	1705	mechanisms	mechanism	I-NP	NNS	O	15	PMOD	O
O	O	1706	1716	underlying	underlie	B-VP	VBG	O	17	NMOD	O
O	O	1717	1720	the	the	B-NP	DT	O	21	NMOD	O
O	O	1721	1730	inducible	inducible	I-NP	JJ	O	21	NMOD	O
O	O	1731	1741	expression	expression	I-NP	NN	O	18	OBJ	O
O	O	1742	1744	of	of	B-PP	IN	O	21	NMOD	O
T30	B-Entity	1745	1750	kappa	kappa	B-NP	NN	B-DNA	27	NMOD	B-DNA
T30	I-Entity	1751	1752	B	B	I-NP	NN	I-DNA	27	NMOD	I-DNA
T30	I-Entity	1752	1753	-	-	B-NP	HYPH	I-DNA	27	NMOD	I-DNA
T30	I-Entity	1753	1762	dependent	dependent	I-NP	JJ	I-DNA	27	NMOD	I-DNA
T30	I-Entity	1763	1768	genes	gene	I-NP	NNS	I-DNA	22	PMOD	I-DNA
O	O	1769	1771	in	in	B-PP	IN	O	21	NMOD	O
O	O	1772	1781	microglia	microglia	B-NP	NNS	B-cell_type	28	PMOD	B-cell_type
O	O	1782	1792	stimulated	stimulate	B-VP	VBN	O	29	NMOD	O
O	O	1793	1795	by	by	B-PP	IN	O	30	VMOD	O
T31	B-Entity	1796	1797	A	A	B-NP	NN	O	34	NMOD	O
T31	I-Entity	1798	1802	beta	beta	I-NP	NN	O	34	NMOD	O
T31	I-Entity	1803	1811	peptides	peptide	I-NP	NNS	O	37	NMOD	O
O	O	1812	1815	and	and	O	CC	O	37	NMOD	O
T10	B-Protein	1816	1819	IFN	IFN	B-NP	NN	B-protein	37	NMOD	B-protein
T10	I-Protein	1820	1825	gamma	gamma	I-NP	NN	I-protein	31	PMOD	I-protein
O	O	1825	1826	,	,	O	,	O	31	P	O
O	O	1827	1829	or	or	O	CC	O	31	PMOD	O
O	O	1830	1832	by	by	B-PP	IN	O	31	PMOD	O
O	O	1833	1836	LPS	LPS	B-NP	NN	O	40	PMOD	O
O	O	1836	1837	.	.	O	.	O	5	P	O
